ME Therapeutics Holdings Inc.
METX
CNSX
| 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | 11/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 946.60K | 1.11M | 1.21M | 992.80K | 281.20K |
| Total Receivables | 19.00K | 12.30K | 9.60K | 5.90K | 22.80K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 60.20K | 18.70K | 2.50K | 5.90K | 42.70K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 1.03M | 1.14M | 1.22M | 1.00M | 346.80K |
|
|
|||||
| Total Current Assets | 1.03M | 1.14M | 1.22M | 1.00M | 346.80K |
| Net Property, Plant & Equipment | 79.80K | 100.00 | 100.00 | 100.00 | 100.00 |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 7.80K | -- | -- | -- | -- |
| Total Assets | 1.11M | 1.14M | 1.22M | 1.00M | 346.90K |
|
|
|||||
| Total Accounts Payable | 64.40K | 34.20K | 10.10K | -- | 27.30K |
| Total Accrued Expenses | 22.90K | -- | 21.40K | -- | 1.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 38.10K | -- | -- | -- | 29.50K |
| Total Finance Division Other Current Liabilities | -- | 12.40K | 2.70K | -- | 100.00 |
| Total Other Current Liabilities | -- | 12.40K | 2.70K | -- | 100.00 |
| Total Current Liabilities | 125.40K | 46.60K | 34.30K | -- | 57.90K |
|
|
|||||
| Total Current Liabilities | 125.40K | 46.60K | 34.30K | -- | 57.90K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 41.00K | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 166.40K | 46.60K | 34.30K | -- | 57.90K |
|
|
|||||
| Common Stock & APIC | 4.36M | 4.53M | 4.48M | 3.36M | 3.33M |
| Retained Earnings | -6.31M | -6.33M | -6.03M | -5.69M | -5.59M |
| Treasury Stock & Other | 2.89M | 2.89M | 2.74M | 3.34M | 2.54M |
| Total Common Equity | 947.10K | 1.09M | 1.19M | 1.00M | 289.00K |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 947.10K | 1.09M | 1.19M | 1.00M | 289.00K |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 947.10K | 1.09M | 1.19M | 1.00M | 289.00K |
|
|
|||||
